Clinical trials in cystic fibrosis

Gerd Döring, J. Stuart Elborn, Marie Johannesson, Hugo de Jonge, Matthias Griese, Alan Smyth, Harry Heijerman

Research output: Contribution to journalLiterature review

39 Citations (Scopus)

Abstract

In patients with cystic fibrosis (CF), clinical trials are of paramount importance. Here, the current status of drug development in CF is discussed and future directions highlighted. Methods for pre-clinical testing of drugs with potential activity in CF patients including relevant animal models are described. Study design options for phase II and phase III studies involving CF patients are provided, including required patient numbers, safety issues and surrogate end point parameters for drugs, tested for different disease manifestations. Finally, regulatory issues for licensing new therapies for CF patients are discussed, including new directives of the European Union and the structure of a European clinical trial network for clinical studies involving CF patients is proposed.
Original languageEnglish
Pages (from-to)85-99
Number of pages15
JournalJournal of Cystic Fibrosis
Volume6
Issue number2
DOIs
Publication statusPublished - Apr 2007

Fingerprint

Cystic Fibrosis
Clinical Trials
Pharmaceutical Preparations
European Union
Licensure
Patient Safety
Animal Models
Biomarkers

Keywords

  • drug development
  • pre-clinical drug testing
  • animal models
  • surrogate end points
  • safety issues
  • drug licensing
  • european clinical trial network for CF
  • Consesnsus study Group

Cite this

Döring, G., Elborn, J. S., Johannesson, M., de Jonge, H., Griese, M., Smyth, A., & Heijerman, H. (2007). Clinical trials in cystic fibrosis. Journal of Cystic Fibrosis, 6(2), 85-99. https://doi.org/10.1016/j.jcf.2007.02.001
Döring, Gerd ; Elborn, J. Stuart ; Johannesson, Marie ; de Jonge, Hugo ; Griese, Matthias ; Smyth, Alan ; Heijerman, Harry. / Clinical trials in cystic fibrosis. In: Journal of Cystic Fibrosis. 2007 ; Vol. 6, No. 2. pp. 85-99.
@article{46ebc9d7a26446d69bdaee26ffe5dfbc,
title = "Clinical trials in cystic fibrosis",
abstract = "In patients with cystic fibrosis (CF), clinical trials are of paramount importance. Here, the current status of drug development in CF is discussed and future directions highlighted. Methods for pre-clinical testing of drugs with potential activity in CF patients including relevant animal models are described. Study design options for phase II and phase III studies involving CF patients are provided, including required patient numbers, safety issues and surrogate end point parameters for drugs, tested for different disease manifestations. Finally, regulatory issues for licensing new therapies for CF patients are discussed, including new directives of the European Union and the structure of a European clinical trial network for clinical studies involving CF patients is proposed.",
keywords = "drug development, pre-clinical drug testing, animal models, surrogate end points, safety issues, drug licensing , european clinical trial network for CF, Consesnsus study Group",
author = "Gerd D{\"o}ring and Elborn, {J. Stuart} and Marie Johannesson and {de Jonge}, Hugo and Matthias Griese and Alan Smyth and Harry Heijerman",
year = "2007",
month = "4",
doi = "10.1016/j.jcf.2007.02.001",
language = "English",
volume = "6",
pages = "85--99",
journal = "Journal of Cystic Fibrosis",
issn = "1569-1993",
publisher = "Elsevier Inc.",
number = "2",

}

Döring, G, Elborn, JS, Johannesson, M, de Jonge, H, Griese, M, Smyth, A & Heijerman, H 2007, 'Clinical trials in cystic fibrosis', Journal of Cystic Fibrosis, vol. 6, no. 2, pp. 85-99. https://doi.org/10.1016/j.jcf.2007.02.001

Clinical trials in cystic fibrosis. / Döring, Gerd; Elborn, J. Stuart; Johannesson, Marie; de Jonge, Hugo; Griese, Matthias; Smyth, Alan; Heijerman, Harry.

In: Journal of Cystic Fibrosis, Vol. 6, No. 2, 04.2007, p. 85-99.

Research output: Contribution to journalLiterature review

TY - JOUR

T1 - Clinical trials in cystic fibrosis

AU - Döring, Gerd

AU - Elborn, J. Stuart

AU - Johannesson, Marie

AU - de Jonge, Hugo

AU - Griese, Matthias

AU - Smyth, Alan

AU - Heijerman, Harry

PY - 2007/4

Y1 - 2007/4

N2 - In patients with cystic fibrosis (CF), clinical trials are of paramount importance. Here, the current status of drug development in CF is discussed and future directions highlighted. Methods for pre-clinical testing of drugs with potential activity in CF patients including relevant animal models are described. Study design options for phase II and phase III studies involving CF patients are provided, including required patient numbers, safety issues and surrogate end point parameters for drugs, tested for different disease manifestations. Finally, regulatory issues for licensing new therapies for CF patients are discussed, including new directives of the European Union and the structure of a European clinical trial network for clinical studies involving CF patients is proposed.

AB - In patients with cystic fibrosis (CF), clinical trials are of paramount importance. Here, the current status of drug development in CF is discussed and future directions highlighted. Methods for pre-clinical testing of drugs with potential activity in CF patients including relevant animal models are described. Study design options for phase II and phase III studies involving CF patients are provided, including required patient numbers, safety issues and surrogate end point parameters for drugs, tested for different disease manifestations. Finally, regulatory issues for licensing new therapies for CF patients are discussed, including new directives of the European Union and the structure of a European clinical trial network for clinical studies involving CF patients is proposed.

KW - drug development

KW - pre-clinical drug testing

KW - animal models

KW - surrogate end points

KW - safety issues

KW - drug licensing

KW - european clinical trial network for CF

KW - Consesnsus study Group

UR - http://www.scopus.com/inward/record.url?partnerID=yv4JPVwI&eid=2-s2.0-33847787485&md5=13c9976f13304b321cd27e117ca4d091

U2 - 10.1016/j.jcf.2007.02.001

DO - 10.1016/j.jcf.2007.02.001

M3 - Literature review

AN - SCOPUS:33847787485

VL - 6

SP - 85

EP - 99

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

SN - 1569-1993

IS - 2

ER -

Döring G, Elborn JS, Johannesson M, de Jonge H, Griese M, Smyth A et al. Clinical trials in cystic fibrosis. Journal of Cystic Fibrosis. 2007 Apr;6(2):85-99. https://doi.org/10.1016/j.jcf.2007.02.001